Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare
Recursion Pharmaceuticals, Inc. Revenue 2019–2025
Recursion Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Recursion Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 6.5 M, a 56.11% decrease year-over-year.
- Recursion Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 45.6 M, a 29.63% decrease year-over-year.
- Recursion Pharmaceuticals, Inc. annual revenue for 2025 was 74.7 M, a 26.92% increase from 2024.
- Recursion Pharmaceuticals, Inc. annual revenue for 2024 was 58.8 M, a 32.00% increase from 2023.
- Recursion Pharmaceuticals, Inc. annual revenue for 2023 was 44.6 M, a 11.88% increase from 2022.
- Recursion Pharmaceuticals, Inc. annual revenue for 2022 was 39.8 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Recursion Pharmaceuticals, Inc. Market Cap — FAQ
Recursion Pharmaceuticals, Inc. (RXRX) market cap over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXRX's market cap history?
The chart and table above show Recursion Pharmaceuticals, Inc.'s market cap by year and by quarter, including the growth rate.